These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9182477)

  • 21. The influence of pregnancy on human immunodeficiency virus type 1 infection: antepartum and postpartum changes in human immunodeficiency virus type 1 viral load.
    Burns DN; Landesman S; Minkoff H; Wright DJ; Waters D; Mitchell RM; Rubinstein A; Willoughby A; Goedert JJ
    Am J Obstet Gynecol; 1998 Feb; 178(2):355-9. PubMed ID: 9500499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people.
    Vitiello B; Goodkin K; Ashtana D; Shapshak P; Atkinson JH; Heseltine PN; Eaton E; Heaton R; Lyman WD
    AIDS; 2007 Jul; 21(11):1415-22. PubMed ID: 17589187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AIDS myelopathy is not associated with elevated HIV viral load in cerebrospinal fluid.
    Geraci A; Di Rocco A; Liu M; Werner P; Tagliati M; Godbold J; Simpson D; Morgello S
    Neurology; 2000 Aug; 55(3):440-2. PubMed ID: 10932285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biology of HIV-1 in women and men.
    Burger H; Weiser B
    Obstet Gynecol Clin North Am; 1997 Dec; 24(4):731-42. PubMed ID: 9430164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection.
    Berry N; Ariyoshi K; Jaffar S; Sabally S; Corrah T; Tedder R; Whittle H
    J Hum Virol; 1998; 1(7):457-68. PubMed ID: 10195267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome.
    Dickover RE; Dillon M; Leung KM; Krogstad P; Plaeger S; Kwok S; Christopherson C; Deveikis A; Keller M; Stiehm ER; Bryson YJ
    J Infect Dis; 1998 Aug; 178(2):375-87. PubMed ID: 9697717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Volunteers needed for study of HIV viral load test.
    Doepel LK
    NIAID AIDS Agenda; 1995 Dec; ():3. PubMed ID: 11363351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel clinical trial designs and HIV-1 RNA assessments with end-point and real-time PCR tests.
    Vilchez RA
    AIDS; 2012 Jul; 26(11):1453-4. PubMed ID: 22767348
    [No Abstract]   [Full Text] [Related]  

  • 29. Discontinuing combination antiretroviral therapy during the first trimester of pregnancy: insights from plasma human immunodeficiency virus-1 RNA viral load and CD4 cell count.
    Bucceri AM; Somigliana E; Matrone R; Uberti-Foppa C; Viganò P; Vignali M
    Am J Obstet Gynecol; 2003 Aug; 189(2):545-51. PubMed ID: 14520232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression.
    Modjarrad K; Chamot E; Vermund SH
    AIDS; 2008 Oct; 22(16):2179-85. PubMed ID: 18832881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy.
    Anastos K; Barrón Y; Cohen MH; Greenblatt RM; Minkoff H; Levine A; Young M; Gange SJ
    Ann Intern Med; 2004 Feb; 140(4):256-64. PubMed ID: 14970148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working Groups.
    Coombs RW; Welles SL; Hooper C; Reichelderfer PS; D'Aquila RT; Japour AJ; Johnson VA; Kuritzkes DR; Richman DD; Kwok S; Todd J; Jackson JB; DeGruttola V; Crumpacker CS; Kahn J
    J Infect Dis; 1996 Oct; 174(4):704-12. PubMed ID: 8843206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure to quantify viral load with two of the three commercial methods in a pregnant woman harboring an HIV type 1 subtype G strain.
    Debyser Z; Van Wijngaerden E; Van Laethem K; Beuselinck K; Reynders M; De Clercq E; Desmyter J; Vandamme AM
    AIDS Res Hum Retroviruses; 1998 Mar; 14(5):453-9. PubMed ID: 9546805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guidelines for laboratory test result reporting of human immunodeficiency virus type 1 ribonucleic acid determination. Recommendations from a CDC working group. Centers for Disease Control.
    Centers for Disease Control and Prevention
    MMWR Recomm Rep; 2001 Nov; 50(RR-20):1-12. PubMed ID: 11952031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex differences in HIV-1 viral load and progression to AIDS.
    Farzadegan H; Hoover DR; Astemborski J; Lyles CM; Margolick JB; Markham RB; Quinn TC; Vlahov D
    Lancet; 1998 Nov; 352(9139):1510-4. PubMed ID: 9820299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Nucleic acid -based testing for HIV infection].
    Adachi A
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():342-6. PubMed ID: 16416816
    [No Abstract]   [Full Text] [Related]  

  • 37. In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to <5 copies per milliliter, with a half-life of 6 months.
    Di Mascio M; Dornadula G; Zhang H; Sullivan J; Xu Y; Kulkosky J; Pomerantz RJ; Perelson AS
    J Virol; 2003 Feb; 77(3):2271-5. PubMed ID: 12525664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral load and response to treatment of HIV.
    Fessel WJ
    N Engl J Med; 1996 Jun; 334(25):1672; author reply 1672-3. PubMed ID: 8628374
    [No Abstract]   [Full Text] [Related]  

  • 39. Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 Team.
    Welles SL; Jackson JB; Yen-Lieberman B; Demeter L; Japour AJ; Smeaton LM; Johnson VA; Kuritzkes DR; D'Aquila RT; Reichelderfer PA; Richman DD; Reichman R; Fischl M; Dolin R; Coombs RW; Kahn JO; McLaren C; Todd J; Kwok S; Crumpacker CS
    J Infect Dis; 1996 Oct; 174(4):696-703. PubMed ID: 8843205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1 envelope diversity 1 year after seroconversion predicts subsequent disease progression.
    Rachinger A; Kootstra NA; Gijsbers EF; van den Kerkhof TL; Schuitemaker H; van 't Wout AB
    AIDS; 2012 Jul; 26(12):1517-22. PubMed ID: 22555160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.